Fosun Pharmaceutical seeks $594 million from HK listing

Prudential agrees to buy $50 million worth of shares, bringing the total cornerstone investment to $75 million.

<div style="text-align: left;"> Back to work: Fosun is the first new listing in Hong Kong for three months </div>

Anette Jönsson

October 17, 2012

Shanghai Fosun Pharmaceutical (Group) yesterday kicked off the institutional roadshow and bookbuilding for the first Hong Kong listing in three months and the biggest since Yitai Coal raised $902 million in early July. As such, the deal will be extremely important as a gauge of investor appetite for Chinese companies.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.